相关实验视频

Updated: Jul 13, 2025

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.7K

解决阿尔茨海默病的异质性基于个性化的结构共变网络

Chuchu Zheng1, Wei Zhao1, Zeyu Yang1

  • 1School of Mathematics and Statistics, Hunan Normal University, Changsha 410006, China; Key Laboratory of Applied Statistics and Data Science, Hunan Normal University, College of Hunan Province, Changsha 410006, China.

Progress in neuro-psychopharmacology & biological psychiatry
|October 12, 2023
PubMed
概括

研究人员通过个性化结构共变性网络 (IDSCN) 分析确定了两种不同的阿尔茨海默病 (AD) 亚型. 这些亚型表现出独特的神经生物学机制和认知轨迹,为AD治疗准确医学方法铺平了道路.

关键词:
阿尔茨海默病的疾病阿尔茨海默病的疾病.功能注释功能注释基因表达特征 基因表达特征异质性 异质性 异质性个性化结构协同变异网络.副类型 副类型 副类型

更多相关视频

Basics of Multivariate Analysis in Neuroimaging Data06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K
Modeling the Functional Network for Spatial Navigation in the Human Brain05:55

Modeling the Functional Network for Spatial Navigation in the Human Brain

Published on: October 13, 2023

1.1K

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
503
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
211